Hanim Halim
Research Subjects
Hanim Halim has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Wayne Purcell
Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia
2 shared publications - Stephanie Gras
GenomEast platform, IGBMC, 67404 Illkirch, France
2 shared publications Anja Greule
Monash University, Australia
1 shared publicationCarine Farenc
Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University , Clayton, Victoria 3800
1 shared publicationJamie Rossjohn
Biochemistry & Molecular Biology, Monash University, Australia
1 shared publication- Jamie Rossjohn
Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia
1 shared publication
Latest Publications
- 15 September 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (6) , 1524-1534
A Shared TCR Bias toward an Immunogenic EBV Epitope Dominates in HLA-B*07:02–Expressing Individuals
EBV is one of the most common viruses found in humans and is prototypic of a persistent viral infection characterized by periods of latency. Across many HLA class I molecules, the latent-specific CD8+ T cell response is focused on epitopes derived from the EBNA-3 protein family. In the case of HLA-B*07:02 restriction, a highly frequent class I allele, the T cell response is dominated by an epitope spanning residues 379–387 of EBNA-3 (RPPIFIRRL [EBVRPP]). However, little is known about either the TCR repertoire specific for this epitope or the molecular basis for this observed immunodominance. The EBVRPP CD8+ T cell response was common among both EBV-seropositive HLA-B*07:02+ healthy and immunocompromised individuals. Similar TCRs were identified in EBVRPP–specific CD8+ T cell repertoires across multiple HLA-B7+ individuals, indicating a shared Ag-driven bias in TCR usage. In particular, TRBV4-1 and TRAV38 usage was observed in five out of six individuals studied. In this study, we report the crystal structure of a TRBV4-1+ TCR–HLA-B*07:02/EBVRPP complex, which provides a molecular basis for the observed TRBV4-1 bias. These findings enhance our understanding of the CD8+ T cell response toward a common EBV determinant in HLA-B*07:02+ individuals. Key Points Shared bias of TRBV4-1 dominates the HLA-B7 EBVRPP–specific CD8+ T cell response. Key residues of TRBV4-1 CDR1/2 loops interact with the HLA-B7/EBVRPP complex.
- 15 September 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (6) , 1524-1534
A Shared TCR Bias toward an Immunogenic EBV Epitope Dominates in HLA-B*07:02–Expressing Individuals
EBV is one of the most common viruses found in humans and is prototypic of a persistent viral infection characterized by periods of latency. Across many HLA class I molecules, the latent-specific CD8+ T cell response is focused on epitopes derived from the EBNA-3 protein family. In the case of HLA-B*07:02 restriction, a highly frequent class I allele, the T cell response is dominated by an epitope spanning residues 379–387 of EBNA-3 (RPPIFIRRL [EBVRPP]). However, little is known about either the TCR repertoire specific for this epitope or the molecular basis for this observed immunodominance. The EBVRPP CD8+ T cell response was common among both EBV-seropositive HLA-B*07:02+ healthy and immunocompromised individuals. Similar TCRs were identified in EBVRPP–specific CD8+ T cell repertoires across multiple HLA-B7+ individuals, indicating a shared Ag-driven bias in TCR usage. In particular, TRBV4-1 and TRAV38 usage was observed in five out of six individuals studied. In this study, we report the crystal structure of a TRBV4-1+ TCR–HLA-B*07:02/EBVRPP complex, which provides a molecular basis for the observed TRBV4-1 bias. These findings enhance our understanding of the CD8+ T cell response toward a common EBV determinant in HLA-B*07:02+ individuals. Key Points Shared bias of TRBV4-1 dominates the HLA-B7 EBVRPP–specific CD8+ T cell response. Key residues of TRBV4-1 CDR1/2 loops interact with the HLA-B7/EBVRPP complex.
- Open Access
- 1 December 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (52) , 20185-20195
Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation
- 1 December 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (52) , 20185-20195
Open AccessAllelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation